glp 1 atherosclerosis GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies GLP-1 receptor agonists as promising

Because peptide therapies are still an emerging area of medicine, quality and sourcing are extremely important

A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users

Which GLP-1 is the Best for Weight Loss

Studies with a mean age of less than 65 were excluded

R Foundation for Statistical Computing, Vienna, Austria) was used for plotting, TTO analysis, and calculation of IC and

10.1111/joim.12837